ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Panel Clear On Breast Conservation, Not On Adjuvant Therapy For Node

June 29, 1990

House Appropriators Approve NIH Increase; Clinton Threatens Veto Over Education Cuts

July 17, 1998

Correcting the Error: What U.S. News Could and Couldn’t Do to Fix the Problem

July 19, 2013

Tobacco Control: Surgeon General Finds Increase In Smoking By Minority Teens

May 1, 1998

Pacific Yew Act Would Result In Duplications, Delays In Taxol Production, Witnesses Say

March 13, 1992

In Brief: Medical School Deans Biggest Enemy Of Cancer Program, Saunders Says; House Oks Line Item

May 16, 1980